Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema

NCT01627249 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT01627249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01627249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
April 18, 2019
Enrollment
660 (actual)
Sites
90

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema